Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis

Fertility and Sterility

Volumn 92, Issue 6, 2009, Pages 1953-1959

  Smith, Laura P ^a   Hacker, Michele R ^a   Alper, Michael M ^a  

^a BOSTON IVF   (United States)

Author keywords

Ovarian hyperstimulation syndrome; paracentesis

Indexed keywords

ESTRADIOL;

ARTICLE; DISEASE SEVERITY; ECHOGRAPHY; ESTRADIOL BLOOD LEVEL; FEMALE; HOSPITALIZATION; HUMAN; INFERTILITY THERAPY; MAJOR CLINICAL STUDY; OUTPATIENT CARE; OVARY HYPERSTIMULATION; PARACENTESIS; PREGNANCY OUTCOME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; TRANSVAGINAL PARACENTESIS;

FEMALE; FERTILIZATION IN VITRO; HOSPITALIZATION; HUMANS; INFERTILITY, FEMALE; OUTPATIENTS; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PARACENTESIS; PREGNANCY; PREGNANCY OUTCOME; SEVERITY OF ILLNESS INDEX; VAGINA;

EID: 70949085132     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.09.011     Document Type: Article

References (39)

1. Aboulghar M.A., and Mansour R.T. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventative measures. Hum Reprod Update 9 (2003) 275-289
2. Tollan A., Holst N., Forsdahl F., Fadnes H.O., Oian P., and Maltau J.M. Transcapillary fluid dynamics during ovarian stimulation for in vitro fertilization. Am J Obstet Gynecol 162 (1990) 554-558
3. Goldsman M.P., Pedram A., Dominguez C.E., Ciuffardi I., Levin E., and Asch R.H. Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. [see comments]. Fertil Steril 64 (1995) 871-872
4. Paul M., Mehr A.P., and Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 86 (2006) 747-803
5. Lightman A., Tarlatzis B.C., Rzasa P.J., Culler M.D., Caride V.J., Negro-Vilar A.F., et al. The ovarian renin-angiotensin system: renin-like activity and angiotensin II/III immunoreactivity in gonadotropin-stimulated and unstimulated follicular fluid. Am J Obstet Gynecol 156 (1987) 808-816
6. Wang T.-H., Horng S.-G., Chang C.-L., Wu H.-M., Tsai Y.-J., Wang H.-S., et al. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. J Clin Endocrinol Metab 87 (2002) 3300-3308
7. Pau E., Alonso-Muriel I., Gomez R., Novella E., Ruiz A., Garcia-Velasco J.A., et al. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome. Hum Reprod 21 (2006) 1453-1460
8. Chen C.-D., Chen H.-F., Lu H.-F., Chen S.-U., Ho H.-N., and Yang Y.-S. Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome. Hum Reprod 15 (2000) 1037-1042
9. Abramov Y., Schenker J.G., Lewin A., Friedler S., Nisman B., and Barak V. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum Reprod 11 (1996) 1381-1386
10. Rabau E., David A., Serr D.M., Mashiach S., and Lunenfeld B. Human menopausal gonadotropin for anovulation and sterility. Am J Obstet Gynecol 98 (1967) 92-98
11. Golan A., Ron-el R., Herman A., Soffer Y., Weinraub Z., and Caspi E. Ovarian hyperstimulation syndrome: an updated review. Obstet Gynecol Surv 44 (1989) 430-440
12. Whelan J.G., and Vlahos N.F. The ovarian hyperstimulation syndrome. Fertil Steril 73 (2000) 883-896
13. Delvigne A., and Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome: a review. Hum Reprod Update 8 (2002) 559-577
14. Rizk B., and Aboulghar M. Modern management of ovarian hyperstimulation syndrome. Hum Reprod 6 (1991) 1082-1087
15. Brinsden P.R., Wada I., Tan S.L., Balen A., and Jacobs H.S. Diagnosis, prevention, and management of ovarian hyperstimulation syndrome. Br J Obstet Gynecol 102 (1995) 767-772
16. Klemetti R., Sevon T., Gissler M., and Hemminki E. Complications of IVF and ovulation induction. Hum Reprod 20 (2005) 3293-3300
17. Delvigne A., and Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update 9 (2003) 77-96
18. Morris R.S., Miller C., Jacobs L., and Miller K. Conservative management of ovarian hyperstimulation syndrome. J Reprod Med 40 (1995) 711-714
19. Vlahos N.F., and Gregoriou O. Prevention and management of ovarian hyperstimulation syndrome. Ann NY Acad Sci 1092 (2006) 247-264
20. Padilla S.L., Zamaria S., Baramki T.A., and Garcia J.E. Abdominal paracentesis for the ovarian hyperstimulation syndrome with severe pulmonary compromise. Fertil Steril 58 (1990) 249-261
21. Aboulghar M.A., Mansour R.T., Serour G.I., Sattar M.A., Amin Y.M., and Elattar I. Management of severe ovarian hyperstimulation syndrome by ascitic fluid aspiration and intensive intravenous fluid therapy. Obstet Gynecol 81 (1993) 108-111
22. Lincoln S.R., Opsahl M.S., Blauer K.L., Black S.H., and Schulman J.D. Aggressive outpatient treatment of ovarian hyperstimulation syndrome with ascites using transvaginal culdocentesis and intravenous albumin minimizes hospitalization. J Assist Reprod Genet 19 (2002) 159-163
23. Fluker M.R., Copeland J.E., and Yuzpe A.A. An ounce of prevention: outpatient management of the ovarian hyperstimulation syndrome. Fertil Steril 73 (2000) 821-824
24. Forouzandeh B., Konicek F., and Sheagren J.N. Large-volume paracentesis in the treatment of cirrhotic patients with refractory ascites: the role of postparacentesis volume expansion. J Clin Gastroenterol 22 (1996) 207-210
25. Cabrera J., Falcon L., Gorriz E., Pardo M.D., Granados R., Quinones A., et al. Abdominal decompression plays a major role in early post paracentesis hemodynamic changes in cirrhotic patients with tense ascites. Gut 48 (2001) 384-389
26. Maslovitz S., Jaffa A., Eytan O., Wolman I., Many A., Lessing J.B., et al. Renal blood flow alteration after paracentesis in women with ovarian hyperstimulation. Obstet Gynecol 104 (2004) 321-326
27. Delbaere A., Bergmann P.J., Gervy-Decoster C., Staroukine M., and Englert Y. Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management. Fertil Steril 62 (1994) 731-737
28. Chen C.-D., Yang J.-H., Chao K.-H., Chen S.-U., Ho H.-N., and Yang Y.-S. Effects of repeated abdominal paracentesis on uterine and intraovarian haemodynamics and pregnancy outcome in severe ovarian hyperstimulation syndrome. Hum Reprod 13 (1998) 2077-2081
29. Levin I., Pharm B., Almog B., Avni A., Baram A., Lessing J.B., et al. Effect of paracentesis of ascitic fluids on urinary output and blood indices in patients with severe ovarian hyperstimulation syndrome. Fertil Steril 77 (2002) 986-988
30. Raziel A., Friedler S., Schachter M., Strassburger D., Bukovsky I., and Ron-El R. Transvaginal drainage of ascites as an alternative to abdominal paracentesis in patients with severe ovarian hyperstimulation syndrome, obesity, and generalized edema. Fertil Steril 69 (1998) 780-783
31. American Society for Reproductive Medicine Practice Committee educational bulletin: ovarian hyperstimulation syndrome. Fertil Steril 86 (2006) S178-S183
32. Aboulghar M.A., Mansour R.T., Serour G.I., and Amin Y. Ultrasonically guided vaginal aspiration of ascites in the treatment of ovarian hyperstimulation syndrome. Fertil Steril 53 (1990) 933-935
33. Abramov Y., Elchalal U., and Schenker J.G. Pulmonary manifestations of severe ovarian hyperstimulation syndrome: a multicenter study. Fertil Steril 71 (1999) 645-651
34. Shrivastav P., Nadkarni P., and Craft I. Day care management of severe ovarian hyperstimulation syndrome avoids hospitalization and morbidity. Hum Reprod 9 (1994) 812-824
35. Al-Ramahi M., Leader A., Claman P., and Spence J. Case report: a novel approach to the treatment of ascites associated with ovarian hyperstimulation syndrome. Hum Reprod 12 (1997) 2614-2616
36. Abuzeid M.I., Nassar Z., Massaad Z., Weiss M., Ashraf M., and Fakih M. Pigtail catheter for the treatment of ascites associated with ovarian hyperstimulation syndrome. Hum Reprod 18 (2003) 370-373
37. Chan C.C., Yin C.S., Lan S.C., Chen I.C., and Wu G.J. Continuous abdominal paracentesis for management of late type severe ovarian hyperstimulation syndrome. J Chin Med Assoc 67 (2004) 197-199
38. Bellver J., Munoz E.A., Ballesteros A., Soares S.R., Bosch E., Simon C., et al. Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study. Hum Reprod 18 (2003) 2283-2288
39. Gokmen O., Ugur M., Ekin M., Keles G., Turan C., and Oral H. Intravenous albumin versus hydroxyethyl starch for the prevention of ovarian hyperstimulation in an in vitro fertilization programme: a prospective, randomized, placebo controlled study. Eur J Obstet Gynecol Reprod Biol 96 (2001) 187-192